Violich Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.75M Buy
3,241
+1,950
+151% +$2.3M 0.4% 39
2026
Q2
$1.55M Sell
1,291
-355
-22% -$363K 0.17% 55
2026
Q1
$1.51M Buy
1,646
+200
+14% +$203K 0.18% 57
2025
Q4
$1.55M Buy
+1,446
New +$1.38M 0.17% 55

Other funds holding LLY

Violich Capital Management's LLY Position: Q3 2026 in Review

Violich Capital Management increased its Eli Lilly (LLY) stake by 151% in Q3 2026, buying an estimated $2.3M and bringing the position to 3,241 shares worth $3.75M. The position accounts for 0.4% of the portfolio, ranked #39.

Violich Capital Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Violich Capital Management held 3,241 shares of Eli Lilly worth $3.75M as of Q3 2026.
  • Violich Capital Management bought 1,950 Eli Lilly shares in Q3 2026, an estimated $2.3M.
  • Eli Lilly made up 0.4% of Violich Capital Management's portfolio in Q3 2026, its #39 holding.
  • Violich Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Violich Capital Management's 13F filing for Q3 2026, filed 5 Oct 2026.